Compare

Acurx Pharmaceuticals, Inc. vs Silo Pharma, Inc. vs Rocket One Inc. vs Oncolytics Biotech Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Acurx Pharmaceuticals, Inc. ACXP	Silo Pharma, Inc. SILO	Rocket One Inc. RKTO	Oncolytics Biotech Inc ONCY
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	$72.1K	n/a	n/a
Revenue growth (YoY)	n/a	0.0%	n/a	n/a
Gross margin	n/a	38.6%	n/a	n/a
Operating margin	n/a	n/m	n/a	n/a
Net margin	n/a	n/m	n/a	n/a
Net income	-$7.97M	-$4.23M	-$12.47M	-$28.76M
EPS (Diluted)	-$5.32	-$0.50	-$0.90	-$0.30
Operating cash flow	-$6.79M	-$4.66M	-$9.80M	-$20.11M
Free cash flow	n/a	n/a	n/a	-$20.12M
Cash & equivalents	n/a	$4.75M	$6.25M	$5.20M
Total assets	$7.69M	$7.61M	$7.60M	$7.58M
Total liabilities	$2.42M	$1.30M	$1.45M	$11.38M
Shareholders' equity	$5.27M	$6.31M	$6.15M	-$3.80M
Return on year-end equity	-151.2%	-67.0%	-202.7%	n/a
Shares outstanding	2.35M	13.32M	15.51M	108.02M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Acurx Pharmaceuticals, Inc.	Silo Pharma, Inc.	Rocket One Inc.	Oncolytics Biotech Inc
Latest	n/a	$72.1K Ended 2025-12-31	n/a	n/a
1 year earlier	n/a	$72.1K Ended 2024-12-31	n/a	n/a
2 years earlier	n/a	$72.1K Ended 2023-12-31	n/a	n/a
3 years earlier	n/a	$72.1K Ended 2022-12-31	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a